Advances in determining new treatments for hepatitis B infection by utilizing existing and novel biomarkers.
Lung-Yi MakRex Wan-Hin HuiKa-Shing CheungJames FungWai-Kay SetoMan-Fung YuenPublished in: Expert opinion on drug discovery (2023)
Novel serum viral biomarkers and immunological markers are indispensable in the HBV functional cure program. These will likely become part of standard monitoring soon.